Corporate Finance Hurdle Rate Pharmaceutical 
CFO News Room
JANUARY 18, 2023
In my last post, I noted the decline in costs of capital for firms over time, noting that the median cost of capital at the start of 2022 is only 6.33%, across global firms, and argued that companies that demand double-digit hurdle rates risk being shut out of investments.
Musings on Markets
FEBRUARY 27, 2022
In my last post, I noted the decline in costs of capital for firms over time, noting that the median cost of capital at the start of 2022 is only 6.33%, across global firms, and argued that companies that demand double-digit hurdle rates risk being shut out of investments.
Expert insights. Personalized for you.
130 
Let's personalize your content